XERS Market Cap History
Below is a table of the XERS market cap history going back to 6/21/2018:

Date XERS Market Cap

Also see: XERS Shares Outstanding History
and XERS YTD Return
XERS Historical Market Cap:
-12.25% CAGR
XERS Historical Market Cap: +-12.25% CAGR

Mouse over chart for data details
6/21/2018 ...10/31/2022
Xeris Biopharma Holdings is a pharmaceutical company. Co.'s primary focus is on therapies for patient populations in endocrinology, neurology, and gastroenterology. Co.'s products include: Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes ages two years and older; Keveyis, the U.S. Food and Drug Administration approved therapy for hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev (levoketoconazole), a cortisol synthesis inhibitor used for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. We show 20 historical shares outstanding datapoints in our XERS shares outstanding history coverage, used to compute XERS market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing XERS market cap history over the course of time is important for investors interested in comparing XERS's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of XERS versus a peer is one thing; comparing XERS market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like XERS can fluctuate over the course of history. With this page we aim to empower investors researching XERS by allowing them to research the XERS market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree XERS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Xeris Pharmaceuticals (XERS) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

XFOR Market Cap History
XGN Market Cap History
XLRN Market Cap History
XNCR Market Cap History
XOMA Market Cap History
XON Market Cap History
XRAY Market Cap History
YMAB Market Cap History
YMTX Market Cap History
YTEN Market Cap History
More Healthcare companies »


XERS Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.